مجله دانشگاه علوم پزشکی سبزوار

شماره جاری

بر اساس شماره‌های نشریه

بر اساس نویسندگان

بر اساس موضوعات

نمایه نویسندگان

نمایه کلیدواژه ها

درباره نشریه

اهداف و چشم انداز

اعضای هیات تحریریه

اصول اخلاقی انتشار مقاله

بانک ها و نمایه نامه ها

پیوندهای مفید

فرایند پذیرش مقالات

اخبار و اعلانات

فرم های ضروری نشریه

راهنمای تنظیم مقاله

راهنمای نگارش خلاصه سیاستی

فرم خلاصه سیاستی

مقایسه جنسیتی اثربخشی طرحواره درمانی بافتاری بر بهبود کیفیت زندگی بیماران مبتلا به میگرن

نوع مقاله : مقاله پژوهشی

نویسندگان

1 دانشجوی دکتری روان شناسی، دانشکده علوم تربیتی و روان شناسی، دانشگاه فردوسی، مشهد، ایران

2 استادتمام، گروه روان شناسی، دانشکده علوم تربیتی و روان شناسی، دانشگاه فردوسی مشهد، مشهد، ایران

3 استاد تمام، گروه روان شناسی، دانشکده علوم تربیتی و روان شناسی، دانشگاه فردوسی مشهد، مشهد، ایران.

4 دانشیار گروه روان پزشکی دانشیار گروه روان پزشکی، مرکز تحقیقات روان پزشکی و علوم رفتاری، دانشگاه علوم پزشکی، مشهد ، ایران

چکیده

زمینه و هدف: سردرد میگرنی یک بیماری عصب‌شناختی است که سردردهای متوسط تا شدید را در یک طرف یا دو طرف سر ایجاد می­کند. این پژوهش با هدف مقایسه جنسیتی اثربخشی طرحواره درمانی بافتاری بر بهبود کیفیت زندگی افراد مبتلا به میگرن انجام شد.
مواد و روش­ها: این پژوهش نیمه‌آزمایشی از نوع پیش‌آزمون- پس‌آزمون با گروه کنترل بر روی بیماران مبتلا به میگرن مراجعه‌کننده به درمانگاه‌های مغز و اعصاب بیمارستان قائم و فارابی شهر مشهد انجام شد. 30 بیمار به‌صورت در دسترس، بعد از تشخیص نهایی توسط متخصص مغز و اعصاب انتخاب و به‌صورت تصادفی در دو گروه 15 نفره آزمایش و کنترل قرار گرفتند. جلسات مداخله در 16 جلسه 90 دقیقه‌ای به مدت 4 ماه برای گروه آزمایش اجرا و پرسش‌نامه زمینه‌یابی سلامت (فرم کوتاه) تکمیل شد. داده‌ها با استفاده از نرم‌افزار SPSS26 و تحلیل کواریانس چندمتغیره تحلیل شد.
یافته­ها: نتایج تحلیل کواریانس چندمتغیری نشان داد که طرحواره درمانی بافتاری به‌طور معناداری باعث بهبود سلامت جسمی و روانی در بیماران مبتلا به میگرن شد (01/0>P). نتایج نشان داد که طرحواره درمانی بافتاری باعث بهبود بیشتر سلامت جسمی در زنان مبتلا به میگرن شد اما در مؤلفه سلامت روانی تفاوتی بین زنان و مردان وجود نداشت.
نتیجه‌گیری: بنابراین می­توان نتیجه­گیری کرد که طرحواره درمانی بافتاری در مقایسه با گروه کنترل، تأثیر معناداری بر بهبود کیفیت زندگی بیماران مبتلا به میگرن داشت و برای بهبود سلامت جسمی در زنان اثربخش‌تر بود.

تازه های تحقیق

https://myaccount.google.com/u/1/?hl=en&pli=1

https://pubmed.ncbi.nlm.nih.gov/31596215/

https://myaccount.google.com/?utm_source=chrome-profile-chooser&pli=1

https://www.ncbi.nlm.nih.gov/myncbi/collections/mybibliography/

https://myaccount.google.com/u/2/?hl=en&pli=1

https://pubmed.ncbi.nlm.nih.gov/31596215/

https://myaccount.google.com/u/3/?hl=en&pli=1

https://myaccount.google.com/u/3/?hl=en&pli=1

 

کلیدواژه‌ها

موضوعات

عنوان مقاله [English]

Gender Comparison of the Effectiveness of Tissue Treatment Plan on Improving the Quality of Life of Migraine Patients

نویسندگان [English]

  • Alireza Gol 1
  • Hamideza Ahgamohammadian sherbaf 2
  • Imanullah Bigdeli 3
  • Farhad Farid Hosseini 4

1 Doctoral student of psychology, faculty of educational sciences and psychology, Ferdowsi University, Mashhad, Iran. - - Ferdowsi University, Mashhad, Iran

2 Full Professor Full Professor, Department of Psychology, Faculty of Educational Sciences and Psychology, mashhad Ferdowsi University, Mashhad, Iran

3 Full Professor, Department of Psychology, Faculty of Educational Sciences and Psychology, Mashhad Ferdowsi University, Mashhad, Iran.

4 Associate Professor, Department of Psychiatry, Psychiatry and Behavioral Sciences Research Center, University of Medical Sciences, Mashhad, Iran

چکیده [English]

Introduction: Migraine headache is a chronic neurological disease that varies in frequency and intensity. This research aimed to compare the effectiveness of a tissue therapy plan in improving the quality of life for individuals with migraines, based on gender.
Materials and Methods: The research employed a semi-experimental pre-test/post-test design with a control group. The statistical population included all patients diagnosed with migraines who visited the neurology clinics of Qaim and Farabi hospitals in Mashhad in 1401 (2022). A sample of 30 patients was selected based on availability after final diagnosis by a neurologist and was randomly assigned to two groups of 15: an experimental group and a control group. The intervention comprised 16 sessions, each lasting 90 minutes, conducted over a period of 4 months for the experimental group. Additionally, participants completed a health background questionnaire (short form). Research data were analyzed using SPSS version 26 and multivariate covariance analysis.
Results: The results of the multivariate analysis of covariance indicated that tissue schema therapy significantly improved both physical and mental health in migraine patients (P < 0.01). Further analysis revealed that tissue schema therapy improved the physical health of women with migraines, while there was no significant difference between men and women regarding the mental health component.
Conclusion: Therefore, it can be concluded that, compared to the control group, tissue schema therapy significantly enhanced the quality of life for migraine patients and was particularly effective in improving physical health in women.

کلیدواژه‌ها [English]

  • quality of life
  • tissue therapy scheme
  • patients with migraine
مراجع
  1. Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. Jama, 2013; 310(24): 2622-2630. doi:10.1001/jama.2013.282533.
  2. Grazzi L, Bernstein C, Raggi A, Sansone E, Grignani E, Searl M, et al. ACT for migraine: Effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: Preliminary data of a phase-II, multicentric, randomized, open-label study. Neurol. Sci. 2019; 40 (1): 191–192. doi: 10.1007/s10072-019-03802-w
  3. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017; 372: 307–15. doi: 10.1016/j.jns.2016.11.071
  4. Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the united states: figures and trends from Government Health Studies. Headache. 2018; 58: 496–505. doi: 10.1111/head.13281
  5. AlHarbi FG, & AlAteeq MA. Quality of life of migraine patients followed in neurology clinics in Riyadh, Saudi Arabia. Journal of family & community medicine. 2020; 27(1): 37. DOI: 4103/jfcm.JFCM_185_19
  6. Linde M, & Dahlöf C. Attitudes and burden of disease among self-considered migraineurs—a nation-wide population-based survey in Sweden. Cephalalgia. 2004; 24(6): 455-465. DOI: 1111/j.1468-2982.2004.00703.x
  7. Freitag FG. The cycle of migraine: patients' quality of life during and between migraine attacks. Clinical therapeutics. 2007; 29(5): 939-949. DOI: 1016/j.clinthera.2007.05.008
  8. Goadsby PJ, Barbanti P, Lambru G, Ettrup A, Christoffersen CL, Josiassen MK, et al. Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures. European Journal of Neurology. 2023; 30(4): 1089-1098. DOI: 1111/ene.15670
  9. Almosaiteer SA, Rabbani U, Alharbi BA, & Aldukhayel A. Quality of life and its predictors among patients with migraine in Qassim region, Saudi Arabia: a cross-sectional study. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. 2022; 58(1): 69. DOI:1186/s41983-022-00507-4
  10. Moseley GL. Graded motor imagery for pathologic pain: a randomized controlled trial. Neurology. 2006; 67(12): 2129-2134. doi: 10.1212/01.wnl.0000249112.56935.32. Epub 2006 Nov 2.
  11. Prisnie JC, Sajobi TT, Wang M, Patten SB, Fiest KM, Bulloch AG, et al. Effects of depression and anxiety on quality of life in five common neurological disorders. Gen Hosp Psychiatry. 2018; 52: 58-63. DOI:10.1016/j.genhosppsych. 2018. 03. 009.
  12. ‏ Orr SL, Christie SN, Akiki S, & McMillan Disability, quality of life, and pain coping in pediatric migraine: an observational study. J Child Neurol. 2017; 32 (8): 717-24. DOI:10.1177/ 0883073817702025
  13. Hajvaziri A, Sohrabi F, Ahadi H. The effect of neurofeedback intervention on quality of life, anxiety and stress symptoms of migraine patients. Two Quarterly Journals of Contemporary Psychology. 2018; 14(2): 38-52. Doi: 29252/bjcp.14.2.38
  14. Wells RE, Burch R, Paulsen RH, Wayne PM, Houle T, Loder E. Meditation for migraines: A pilot randomized controlled trial. Headache. 2014; 54: 1484–1495. DOI:1111/head.12420
  15. Jacobs GD. Clinical applications of the relaxation response and mind–body interventions. J. Altern. Complement. Med. 2001; 7 (1): 93–101. DOI: 1089/107555301753393850
  16. Nicholson RA, Buse DC, Andrasik F, & Lipton RB. Nonpharmacologic treatments for migraine and tension-type headache: how to choose and when to use. Current treatment options in neurology. 2011; 13: 28-40. doi: 10.1007/s11940-010-0102-9.
  17. Penzien DB, Irby MB, Smitherman TA, Rains JC, & Houle TT. Well-established and empirically supported behavioral treatments for migraine. Current pain and headache reports. 2015; 19: 1-7. DOI: 1007/s11916-015-0500-5
  18. Sullivan A, Cousins S, & Ridsdale L. Psychological interventions for migraine: a systematic review. Journal of neurology. 2016; 263: 2369-2377. DOI: 1007/s00415-016-8126-z
  19. Holroyd KA, Cottrell CK, O’Donnell FJ, Cordingley GE, Drew JB, Carlson BW, et Effect of preventive (β blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. Bmj. 2010; 341. doi: 10.1136/bmj.c4871.
  20. Hayes SC, Strosahl KD, & Wilson KG. Acceptance and commitment therapy. American Psychological Association Washington. 2009. DOI: 1016/j.brat.2017.05.016
  21. Hughes LS, Clark J, Colclough JA, Dale E, & McMillan D. Acceptance and commitment therapy (ACT) for chronic pain. The Clinical journal of pain, 2017; 33(6): 552-568. doi: 10.1097/AJP.0000000000000425.
  22. Arntz A, Rijkeboer M, Chan E, Fassbinder E, Karaosmanoglu A, Lee CW, et al. Towards a reformulated theory underlying schema therapy: Position paper of an international workgroup. Cognitive Therapy and Research. 2021. https://doi.org/10.1007/s10608-021-10209-5.
  23. Bamelis LL, Evers SM, Spinhoven P, & Arntz A. Results of a multicenter randomized controlled trial of the clinical effectiveness of schema therapy for personality disorders. American Journal of Psychiatry. 2014; 171(3): 305-322.‏ DOI: 1176/appi.ajp.2013.12040518
  24. Carter JD, McIntosh VV, Jordan J, Porter RJ, Frampton CM, & Joyce PR. Psychotherapy for depression: A randomized clinical trial comparing schema therapy and cognitive behavior therapy. Journal of Affective Disorders. 2013; 151(2): 500–505. https://doi.org/10.1016/j.jad.2013.06.034
  25. Pugh M. A narrative review of schemas and schema therapy out- comes in the eating disorders. Clinical Psychology Review. 2015; 39: 30–41. https://doi.org/10.1016/j.cpr.2015.04.003
  26. Ball SA, Maccarelli LM, LaPaglia DM, & Ostrowski MJ. Ran- domized trial of dual-focused versus single-focused individual therapy for personality disorders and substance dependence. Journal of Nervous and Mental Disease. 2011; 199(5): 319–328. https://doi.org/10.1097/NMD.0b013e3182174e6f
  27. Bourdon DE, El-Baalbaki G, Girard D, Lapointe-Blackburn E, & Guay S. Schemas and coping strategies in cognitive-behavioral therapy for PTSD: A systematic review. European Journal of Trauma & 2019; 3(1): 33–47. https://doi.org/10.1016/j.ejtd.2018.09.005
  28. Cockram DM, Drummond PD, & Lee CW. Role and treatment of early maladaptive schemas in Vietnam veterans with PTSD. Clinical Psychology & Psychotherapy. 2010; 17(3): 165– 182.
  29. de Klerk N, Abma TA, Bamelis LL, & Arntz A. Schema therapy for personality disorders: A qualitative study of patients’ and therapists’ perspectives. Behavioural and cognitive psychotherapy. 2017;45(1): 31-45.‏ DOI: 1002/cpp.690
  30. Tan YM, Lee CW, Averbeck LE, Brand-de Wilde O, Farrell J, Fassbinder E, et al. Schema therapy for borderline personality disorder: A qualitative study of patients' perceptions. PLoS ONE. 2018; 13(11): https://doi.org/10.1371/journal.pone.0206039.
  31. Klerk N, Abma TA, Bamelis LL, & Arntz A. Schema therapy for personality disorders: A qualitative study of patients’ and therapists’ perspectives. Behavioural and cognitive psychotherapy. 2017;45(1): 31-45. doi: 10.1017/S1352465816000357
  32. Roediger E, Stevens BA, & Brockman R. Contextual schema therapy: An integrative approach to personality disorders, emotional dysregulation, and interpersonal functioning. California: New Harbinger Publications. 2018. (book)
  33. Heydari M, Mami SH, Ahmadi V, Khamosian K. The effectiveness of schema therapy and cognitive behavioral therapy on self-efficacy and quality of life in women with MS. Applied Family Therapy. 2023; 4(1): 570-554. DOI:61838/kman.aftj.4.1.27
  34. Lins L,  Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE open medicine. 2016; 4: 17-25.https://doi.org/10.1177/2050312116671725
  35. Asghari Moghadam MA, Faqihi S. Validity and reliability of health background questionnaire (short form of 36 questions) in two Iranian samples. Daneshwar Behavat, 2002; 10(1): 1-10. DOI:32598/irjns.5.2.79
  36. Peeters N, van Passel B, & Krans J. The effectiveness of schema therapy for patients with anxiety disorders, OCD, or PTSD: A systematic review and research agenda. British Journal of Clinical Psychology. 2022; 61(3): 579-597.‏ DOI: 1111/bjc.12324
  37. Farhadi M, Pasandideh MM, and Waziri S. The effectiveness of schema therapy on reducing stress, anxiety, depression and increasing self-efficacy in patients with multiple sclerosis. Biannual scientific journal of clinical psychology and personality. 2021; 19(2): 57-69. DOI: https://doi.org/10.5812/mejrh-132571
  38. Cormier A, Jourda B, Laros C, Walburg V, Collahans S. Influence between early maladaptive schemas and depression. Encephale. 2010; 37(4): 293-8. DOI:1016/j.encep.2011.01.001
  39. Yang E, Klosko S, Weishaar E. Schema therapy, a practitioner′s guide. Translation by Hamidpour H, Andouz Z. Tehran: Arjmand. 2011. (book)
  40. Dogaheh ER, Yoosefi A, Kami M. Comparison of maladaptive coping styles in patients with migraine and tension headaches with normal group. Pract Clin Psychol. 2014; 2: 211–9. http://jpcp.uswr.ac.ir/browse.php?a_code=A-10-1-24&slc_lang=en&
  41. Özge A, Valeriani M, Uluduz D, Guidetti V. Cognitive schemas in primary headache disorders. Frontiers in Neurology. 2023; 14: 1240559. DOI: 3389/fneur.2023.1240559
  42. Onur OS, Ertem DH, Karsidag C, Uluduz D, Ozge A, Sıva A, et al. An open/pilot trial of cognitive behavioral therapy in Turkish patients with refractory chronic migraine. Cognitive neurodynamics,. 2019; 13: 183-189. doi: 10.1007/s11571-019-09519-y
  43. Paschali M, Lazaridou A, Vilsmark ES, Lee J, Berry M, Grahl A, et al. The “self” in pain: high levels of schema-enmeshment worsen fibromyalgia impact. BMC Musculoskeletal Disorders. 2021; 22(1): 1-9. DOI: 1186/s12891-021-04740-5
  44. Kolotkin R. L, Crosby R. D, Gress R. E., Hunt S. C, Engel S. G, Adams, T. D. Health and health-related quality of life: differences between men and women who seek gastric bypass surgery. Surgery for Obesity and Related Diseases. 2008; 4(5), 651-658. doi: 10.1016/j.soard.2008.04.012
مجله دانشگاه علوم پزشکی سبزوار
دوره 31، شماره 5
آذر و دی 1403
صفحه 681-692
فایل ها
سابقه مقاله
  • تاریخ دریافت: 12 آذر 1402
  • تاریخ بازنگری: 08 خرداد 1403
  • تاریخ پذیرش: 09 خرداد 1403
هم رسانی
ارجاع به این مقاله
آمار